Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.8B | 13.7B | 14.0B | 13.4B |
Cost of revenue | 4.9B | 5.1B | 5.5B | 5.2B |
Gross profit | 8.9B | 8.5B | 8.5B | 8.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.7B | 2.7B | 2.6B | 2.4B |
Operating income | 2.8B | 2.4B | 2.4B | 2.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 406.8M | 365.8M | 351.3M | 340.2M |
Other income expense | — | — | — | — |
Pretax income | 2.5B | 2.2B | 2.3B | 2.3B |
Tax provision | 567.9M | 257.6M | 329.8M | 301.9M |
Net income | 2.0B | 1.9B | 2.0B | 2.0B |
Basic EPS | — | 9.5 | 9.8 | 9.9 |
Diluted EPS | — | 9.5 | 9.8 | 9.9 |
Basic average shares | — | 203.1M | 203.1M | 203.0M |
Diluted average shares | — | 203.1M | 203.1M | 203.0M |
EBITDA | 3.8B | 3.3B | 3.3B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -740K | -1.2M | -1.7M | -1.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |